In situ gelling drug delivery system
US9566336B2 · kind B2 · utility
0Cited by
15References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 28, 2014 |
| Grant date | Feb 14, 2017 |
| Priority date | — |
| Expiry date | Jul 28, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides liquid controlled-release drug delivery compositions which gel upon injection into the body to form, in situ, controlled-release drug implants. The compositions of the invention feature a gel-forming polymer that is insoluble in water, a polyethylene glycol solvent in which the polymer is dissolved, and the drug substance to be delivered.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.